Bio-Path Holdings, Inc.
P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

Last updated:

Abstract:

Provided herein are methods of treating cancer or an autoimmune disease comprising administering a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide that targets a IGF-1R-encoding polynucleotide.

Status:
Application
Type:

Utility

Filling date:

18 Nov 2021

Issue date:

5 May 2022